Neurocrine Biosciences
Presence
Neurocrine Biosciences is one of the...
Neurocrine Biosciences is a company listed under the stock ticker NBIX (US).
Neurocrine Biosciences has a direct presence in 2 countries.
They are in:
- Biotechnology50%
- Pharmaceuticals50%
Acquisition, funding and merger involving Neurocrine Biosciences.
- Neurocrine Biosciences has acquired Diurnal Group (posted on November 30 2022).
- Neurocrine Biosciences has announced the acquisition of Diurnal Group (posted on August 30 2022).
Executives
View the org chart displaying its 28 main executives
Most searched biographies at Neurocrine Biosciences
- Kevin Gorman, President, Chief Executive Officer and Director
- Shalini Sharp, Director
- Leslie Norwalk, Director
Popular executive movements at Neurocrine Biosciences
- Eiry Roberts, Chief Medical Officer, will leave the company in Jan. 2025 (posted on July 27 2023).
Create your alert
to follow the executive moves at Neurocrine Biosciences.
Biotechnology
Neurocrine Biosciences has 2,276 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Histogen has filed for bankruptcy protection (posted on April 19 2024).
- Bruker has announced the acquisition of NanoString Technologies (posted on April 18 2024).
- Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences (posted on April 16 2024).
Popular contacts in Biotechnology
News
Press releases by Neurocrine Biosciences
- Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2024 Financial Results | Neurocrine Biosciences
- Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating Effects of NBI-1065890, a Second-Generation VMAT2 Inhibitor, in Healthy Adults | Neurocrine Biosciences
- Neurocrine Biosciences Announces First-Patient Dosed in Phase 2 Clinical Study Evaluating NBI-1070770 in Adults with Major Depressive Disorder | Neurocrine Biosciences
- Neurocrine Biosciences to Participate at Virtual Investor Conferences in March | Neurocrine Biosciences
- News & Media | neurocrine.com
- Neurocrine Biosciences to Participate at Investor Conferences in March | Neurocrine Biosciences
- News & Media | neurocrine.com
- Neurocrine Biosciences Launches Interactive Digital Tool for use by Healthcare Providers to Help Expand Education on Identifying and Diagnosing Tardive Dyskinesia | Neurocrine Biosciences
- Neurocrine Biosciences to Present at the Jefferies London Healthcare Conference | Neurocrine Biosciences
- News & Media | neurocrine.com
- View more press releases Close
Social media about Neurocrine Biosciences
- Neurocrine Biosciences on Wikipedia, Google News & Yahoo Finance
- Neurocrine Biosciences on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Kevin Gorman 
Call Neurocrine Biosciences at +1 858...
